-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Worldwide, approximately 700,000 people die each year by suicide, which is 10 to 20 times the number of suicide attempts
The study was completed at seven French teaching hospitals between April 13, 2015 and March 12, 2019
156 participants were recruited and randomly assigned to placebo (n=83) or ketamine (n=73) treatment, stratified by center and diagnosis : bipolar disorder, depression, or other disorders
diagnosis
More subjects receiving ketamine achieved complete resolution of suicidal thoughts on day 3 than subjects receiving placebo: 46 (63.
CONCLUSIONS: The results of this study suggest that ketamine therapy has a rapid onset of short-term, safe, and sustained benefit in the acute treatment of suicidal patients
The results of this study suggest that ketamine therapy has a rapid onset of short-term, safe, and sustained benefit in the acute treatment of suicidal patients
Original source:
Mocrane Abbar, et al.